HFA Premium Access

Infection risk with ferric derisomaltose compared to standard of care in patients with heart failure and iron deficiency: a prespecified analysis of the IRONMAN trial

Congress Presentation

About the speaker

Professor Paul Kalra

Queen Alexandra Hospital, Portsmouth (United Kingdom of Great Britain & Northern Ireland)
9 presentations
3 followers

7 more presentations in this session

GDF15 is linked to congestion-related anorexia and weight loss in advanced HF

Speaker: Doctor V. Melenovsky (Prague, CZ)

Thumbnail

Prognostic impact of co-morbidities on long-term prognosis in patients with reduced and preserved ejection fraction following acute myocardial infarction

Speaker: Assistant Professor L. Savic (Belgrade, RS)

Thumbnail

Clinical experience and safety of ferric carboxymaltose for treating iron deficiency in heart failure patients with mildly reduced and preserved left ventricular ejection fraction.

Speaker: Doctor A. Esteban Fernandez (Leganes, ES)

Thumbnail

Soluble transferrin receptor as a marker of tissue iron deficiency: impact on health-related quality of life in patients with heart failure without systemic iron deficiency or anaemia

Speaker: Mr R. Ramos Polo (Hospitalet De Llobregat, ES)

Thumbnail

Evaluation of intracranial circulation in patients in terminal stage of heart failure before and after heart transplantation

Speaker: Doctor J. Zizka (Prague, CZ)

Thumbnail

Access the full session

Chronic heart failure - clinical

Speakers: Professor P. Kalra, Doctor V. Melenovsky, Assistant Professor L. Savic, Doctor A. Esteban Fernandez, Mr R. Ramos Polo...
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations